These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37907261)

  • 21. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
    Haley M; Bindal P; McAuliffe A; Vredenburgh J
    Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gynecologic Manifestations of the DICER1 Syndrome.
    Stewart CJ; Charles A; Foulkes WD
    Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
    Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
    J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
    Zhang X; Shen D; Wang Y
    Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel pathogenic variant of
    Rivera-Hernández A; Madrigal-González M; Mejía-Carmona L; Martínez-López I; Pérez-Hernández MG; Bernal-Manjarrez J; Luna-Vidal S; Reta-Guerrero S; Rodríguez-Florido MA; Balcázar-Hernández L
    J Pediatr Endocrinol Metab; 2023 Aug; 36(8):782-785. PubMed ID: 37307239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
    Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
    J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
    Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
    Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
    [No Abstract]   [Full Text] [Related]  

  • 34. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
    Hughes CE; Liang J; Paulson V; Wang H
    Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
    [No Abstract]   [Full Text] [Related]  

  • 35. Sertoli-Leydig tumor and DICER1 gene mutation: A case series and literature review.
    Durden AA; Cass GK; Newton C
    J Obstet Gynaecol Res; 2024 Jul; 50(7):1132-1140. PubMed ID: 38599636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
    Bhat RA; Lim YK; Chia YN; Yam KL
    J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
    McCluggage WG; Chong AL; de Kock L; Foulkes WD
    Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian sex cord-stromal tumors--a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry.
    Schneider DT; Jänig U; Calaminus G; Göbel U; Harms D
    Virchows Arch; 2003 Oct; 443(4):549-60. PubMed ID: 12910419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.